v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
RENTAL REVENUE $ 296,165 $ 297,631
OPERATING EXPENSES 248,445 218,448
OPERATING INCOME 47,720 79,183
OTHER OPERATING EXPENSES:    
Advertising and marketing expenses 691,753 526,806
Professional fees 1,226,239 821,308
Compensation and related benefits 451,555 523,045
Research and development expenses 92,350 116,684
Other general and administrative expenses 250,059 218,282
Total Other Operating Expenses 2,711,956 2,206,125
LOSS FROM OPERATIONS (2,664,236) (2,126,942)
OTHER (EXPENSE) INCOME    
Interest expense (154,205)
Interest expense - related party (2,021) (39,686)
Income (loss) from equity method investments 37,285 (12,916)
Other (expense) income (737) 109,006
Total Other (Expense) Income, net (119,678) 56,404
LOSS BEFORE INCOME TAXES (2,783,914) (2,070,538)
INCOME TAXES
NET LOSS (2,783,914) (2,070,538)
LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS (2,783,914) (2,070,538)
COMPREHENSIVE LOSS:    
NET LOSS (2,783,914) (2,070,538)
OTHER COMPREHENSIVE INCOME    
Unrealized foreign currency translation gain 3,670 2,021
COMPREHENSIVE LOSS (2,780,244) (2,068,517)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (2,780,244) $ (2,068,517)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:    
Basic and diluted (in Dollars per share) $ (0.28) $ (0.23)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic and diluted (in Shares) 10,015,637 8,850,244

Source

PDF HTML
ZIP